Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FQVJH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,223
Award facts
- Contract value 100% obligated
- $6,223.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $6,223.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) with an ultimate completion date of September 19, 2025. This non-set-aside contract was awarded competitively on September 18, 2025, with performance to be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as a child contract under its larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 potential value through December 2026.
This delivery order represents a routine pharmaceutical supply transaction within AmerisourceBergen's broader role as a prime vendor supporting military healthcare systems and the Defense Health Agency. The company maintains an extensive portfolio of federal contracts covering a wide spectrum of pharmaceutical products, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The firm fixed-price delivery order structure and modest transaction value are consistent with AmerisourceBergen's demonstrated capability to fulfill federal medical supply needs through open competition, ranging from small-value orders to substantial procurement actions exceeding $45,000. The DLA's Medical Supply Chain relies on such vendor relationships to ensure consistent availability of essential medications and medical supplies to support military readiness and healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FQVJH?
SPE2DB25FQVJH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 18, 2025.
How much is contract SPE2DB25FQVJH worth?
The government has obligated $6,223 on SPE2DB25FQVJH.
Is contract SPE2DB25FQVJH an order under another contract?
Yes. SPE2DB25FQVJH is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVJH competed?
The extent of competition for SPE2DB25FQVJH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award